Regn5678 (Anti-CD28 & PSMA)
Product Specifications
CAS Number
2657613-60-8
Synonyms
Nezastomig
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
REGN5678 is a bispecific antibody targeting both PSMA on prostate cancer cells and CD28 on T-cells to enhance immune activation. It is being developed for the treatment of prostate cancer by redirecting T-cells to PSMA-expressing tumors, promoting tumor cell death. M.W 145.86 kDa
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
129306-HRP 100 µL
MAGEA2 (Melanoma-associated Antigen 2, MAGE-2 Antigen, Cancer/Testis Antigen 1.2, CT1.2, MAGE2, MAGEA2A, MGC131923) (HRP)
Sign In for Pricing
View Details 
128655-PE 100 µL
ITM1 (Dolichyl-diphosphooligosaccharide--protein Glycosyltransferase Subunit STT3A, Oligosaccharyl Transferase Subunit STT3A, STT3-A, B5, Integral Membrane Protein 1, Transmembrane Protein TMC, FLJ27038, MGC9042) (PE)
Sign In for Pricing
View Details 
MBS956245-01 0.02 mg (E-Coli)
Recombinant Human Cytochrome c oxidase subunit 4 isoform 1, mitochondrial
Sign In for Pricing
View Details MBS956245-02 0.1 mg (E-Coli)
Recombinant Human Cytochrome c oxidase subunit 4 isoform 1, mitochondrial
Sign In for Pricing
View Details